Mutations in the STM2 gene cause Familial Alzheimer's disease (AD) in Volga Germans. To understand the function of this protein and how mutations lead to AD, it is important to determine which cell types in the brain express this gene. In situ hybridization histochemistry indicates that STM2 expression in the human brain is widespread and is primarily neuronal. In addition, STMZ mRNA is expressed in a cell line with neuronal origins. Quantification of the level of expression of the !XM2 message in the basal fore-' Box 356560. Univ. of Washington, Seattle, WA 98195. brain, ftontal cortex, and hippocampus reveals a significant decrease in AD-afTected subjects compared to normal agematched controls. These data suggest that downregulation of neuronal STM2 gene expression may be involved in the progression of AD. (]Hisrochem Cyrochem 4X1215-1222, 1%)
Introduction
Alzheimer's disease (AD), the most common type of adult-onset dementia, is a devastating neurological disorder for which there is no known cure. Genetic factors play a major role in the etiology of AD. Late-onset AD, the most common form of the disease, is often associated with inheritance of the E4 allele of the apolipoprotein E gene (apoE) on chromosome 19 (Saunders et al., 1993ab; Strittmatter et al., 1993) . Onset before 60 years of age is less common and is associated with at least three autosomal dominant loci. A small percentage of these familial Alzheimer's disease (FAD) cases are caused by a mutation in the amyloid precursor protein gene (APP) on chromosome 21 (Mullan et al., 1992; Chartier-Harlin et al., 1991; Goate et al., 1991; Murre11 et al., 1991) . Two other genes associated with FAD have recently been identified. Mutations in S182, a gene on chromosome 14, appear to be involved in the majority of early onset FADS . Mutations in a second gene, STM2, located on chromosome 1, have been shown to be involved in the development of FAD in Volga German families and in one other FAD kindred (Levy-Lahad et al., 1995; Rogaev et al., 1995) .
The functions of the recently identified S182 and STMZ proteins are unknown. Sequence analysis indicates that these proteins are approximately 450 amino acids long, contain seven to nine transmembrane domains, and are highly homologous, indicating that they may have similar functions (Levy-Lahad et al., 1995; Rogaev et al., 1995) . Sequence comparisons with other known genes have revealed a high degree of similarity to the Caenorhabdztis elegans sel-12 gene. This gene encodes a multiple transmembrane domain protein that functions in facilitating signaling mediated by lin-12, a member of the Notch family that is involved in determining cell fate (Levitan and Greenwald, 1995) . In addition, STM2 and sl82 show some degree of similarity to the C. elegans spe4 gene, whose product is involved in cytoplasmic partitioning of proteins (L'Hernault and Arduengo, 1992) .
Northern analysis indicates that both 9 8 2 and STMZ encode two transcripts that are differentially expressed in a variety of tissues, including most regions of the brain, the heart, placenta, liver, skeletal muscle, and kidney (Levy-Lahad et al., 1995; Sherringtonet al., 1995) . To understand the CNS functions of the proteins encoded by the STM2 and S182 genes and how mutations in these genes lead to AD, it is important first to determine which cell types in the brain express these genes, especially in regions known to be affected in AD. The present study examined the pattern and relative levels of expression of STMZ mRNA in the brain of both normal and AD-affected individuals by in situ hybridization histochemistry. In addition, to determine if the expression of the STM2 gene in the CNS is primarily neuronal, a human neuroblastoma cell line was also evaluated for expression of this gene.
Materials and Methods
Human Tissue. Five control and five gender-and age-group-matched AD (late-onset sporadic) cases were selected from the Alzheimer's Disease Research Center brain bank at the University ofwashington ('lible 1). Control cases had no significant history of neurologic disease or neuropathological abnormalities. AD caxs had a clinical history of dementia and neuropathological confirmation of the AD diagnosis (Mirra et al., 1991) without concomitant pathological changes such as cerebral infarct and Lewy body inclusions. Frozen tissue from Volga German kindreds was not available for this study. Frozen tissue blocks from the superior frontal gyrus, midhippocampus (lateral geniculate level), basal forebrain (Ch4am) (Mesulam and Geula, 1988) . hypothalamus (tuberal level), midbrain (brachium conjunctivum level). and pons (parabrachial level) were available for use in all 10 cases. A11 blocks were dissected from fresh brain, snap-frozen in liquid nitrogen-cooled isopentane, and stored at -70'c.
Cells and Culture Conditions. The human neuroblastoma SK-N-SH cell line (American Type Culture Collection; Rockville, MD) was grown in Eagle's minimal essential medium (Sigma; St Louis, MO) containing 10% fetal bovine serum (Gibco/BRL; Gaithersburg, MD), 1 mM sodium pyruvate, 1 x penicillin-streptomycin, and 1 x nonessential amino acids at 37'C in a 5% COz incubator. For treatment with nerve growth factor (NGF), cells were grown to 70% confluency and NGF was added at a final concentration of 200 nglml. After 3 days, cells either were harvested for RNA isolation or were split and replated in the presence of fresh medium containing 200 nglml NGF. Replated cells received one change of fresh medium containing the same concentration of NGF on Day 6 and then were harvested for RNA isolation on Day 9.
Probes. The STM2 probe used in this study is a 500-BP fragment containing the 3'-untranslated region (UTR) cloned into Invitrogen's TA Cloning Vector, pCRII (San Diego, CA). For transcription of the STM2 antisense (complementary) riboprobe for use in the in situ hybridization analysis, the plasmid was linearized with BamHI and transcribed with T7 RNA polymerase. Transcription reactions were carried out using Promega's (Madison, WI) Riboprobe Gemini System according to the manufacturer's instructions in the presence of 12 pM [3'S]-UTF! The riboprobe was purified by phenol-chloroform extraction and ethanol precipitation and resuspended in TED buffer (0.1 M Tris, 1 mM ethylenediaminetetra-acetic acid (EDTA), 0.1 M dithiothreitol). The specificity of this probe was previously determined by hybridization with a 3'S-labeled sense (control) riboprobe (data not shown). For use in Northern analysis, the STM2 insert was random-labeled in the presence of [a3*P]-dATP using Stratagene's (La Jolla, CA) Prime-It I1 according to the manufacturer's instructions.
RNA Isolation and Northern Analysis. Total RNA was isolated from untreated or NGF-treated SK-N-SH cells by the guanidium isothiocyanate method (Chomczynski and Sacchi, 1987) . Poly A(+) mRNA was isolated from total RNA using mini-oligo (dT) spin columns (5'-3' Inc.; Boulder, CO), which yielded a preparation of mRNA that was slightly contaminated with non-poly A(+) RNA. The residual ribosomal RNA present in this preparation was used to ensure that the RNA was intact and that equivalent amounts of RNA were analyzed in the Northern analysis (see below). Five pg of poly A( + ) mRNA was subjected to electrophoresis in a 1.2% formaldehyde-agarose denaturing gel, transferred to a nylon membrane, and hybridized overnight with the STM2 probe at 60°C in 6 x SSC (20 x SSC = 3 M NaCI, 0.3 M sodium citrate), 1% SDS, 5 x Denhardt's Solution (50 x Denhardt's = 1% BSA, 1% Ficoll. 1% polyvinylpyrrolidine), pH 7.0, and 1 mg salmon sperm DNA. The filter was then washed in two changes of room-temperature (RT) 2 x SSC-O.1% SDS, and a final wash was done at 60'C in the same solution. The filter was air dried and exposed to Dupont Reflection NEF496 X-ray film (NEN Dupont; Boston, MA). NGF has been reported to enhance the expression of many commonly used controls such as P-actin and cyclophilin (Henke et al.. 1991; Guo and Gorski. 1988; and unpublished observations) . Therefore, to ensure that equivalent amounts of RNA were analyzed from each sample, the hybridization signal was normalized to residual ribosomal RNA that was present in the mRNA preparation (data not shown).
Preparation of Tissue and In Situ Hybridization. Tissue preparation and in situ hybridization procedures were performed as previously described (Shughrue et al., 1992) . Briefly, section-mounted slides were postfixed in 4% paraformaldehyde. treated with acetic anhydride (0.25% in 0.1 M triethanolamine), delipidated, and dehydrated through a graded series of ethanol and chloroform. Section-mounted slides were hybridized overnight under saturating conditions with the 3'S-labeled anti-sense STM2 riboprobe (0.1 pmolklide) at 55 "C. After hybridization, slides were washed in 1 x SSC (150 mM NaCI, 15 mM Na citrate) at RT for 30 min. treated with RNAse buffer (10 mM Tris, pH 8, 0.5 M NaCI, 1 mM EDTA, pH 8, and 20 pglml RNAse A) at 37% for 30 min. and rinsed in 1 x SSC at RT for 30 min. Slides were then washed for 1 hr in three changes of 0.1 x SSC at 55'C, followed by a final wash in the same solution at RT. Slides were then dehydrated through a graded series of alcohols containing ammonium acetate and air-dried. Finally, section-mounted slides were dipped in Kodak NTB2 Nuclear Track emulsion (diluted 1:1 in 0.6 M ammonium acetate) and stored in dry, light-tight boxes at 4% for 3 weeks. The slides were photographically processed, stained with cresyl violet acetate, and mounted with coverslips.
Data Analysis. Analysis of grain counting was performed using a Microcomputer Imaging Device (MCID) (Imaging Research; Saint Catherine's, Ontario, Canada). The relative levels of STM2 mRNA were compared between normal and AD subjects in the CA1 and CA3 fields of the hippocampus, Layers 5/6 of the frontal cortex, and in the basal forebrain (Ch4am) (Mesulam and Geula, 1988) . Before data were analyzed, a double threshold was set that clearly distinguished grains from background, these threshold-selected targets falling within a specific density range. All pixels lying within this density range were regarded by the computer as a target and all other pixels were regarded as background. To improve the accuracy of the counts, a mean target size was determined so that the number oftargets in a cluster of cells could be estimated. Care was taken throughout the analysis to ensure that lighting and background correction were constant for all sections analyzed within a given region. Individual cells were identified under high power ( x 40) by brightfield microscopy. The number of silver grains overlying each labeled cell was then counted under darkfield microscopy. The total number of positively labeled cells was obtained by analysis of three cells from four serial sections (12 cells total) for each subject.
Statistical Analysis. Data are represented as means f SEM. Data were analyzed by a two-way analysis of variance to test for differences in STM2 mRNA levels between normal and AD-affected individuals in each of the regions investigated. Post hoc comparisons were made using a Scheffe test.
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Results
In situ hybridization analysis indicated that STMZ mRNA was expressed to mrious degrees in putative cholinergic neurons in the basal forebrain, as well as in neurons in the supraoptic nucleus. paraventricular nucleus. lateral and preoptic hypothalamus, dentate granule cells. CA1 through CA4 fields of the hippocampus. Layers 2-6 ofthe frontal cortex, raphe nuclei, and substantia nigra. The specificity of the STM2 riboprobe used in this assay was verified by hybridization with a 35S-labeled sense control riboprobe. which failed to demonstrate labeling (data not shown). k a u x the basal forebrain. hippocampus. and cortex are severely affected in AD, the pattern ofexpression and relative levelsof STMZ mRNA were compared in normal and AD-affected individuals in these regions. Representative low-powcr ( x 10 or x 20) darkfield photomicrographs ( Figure 1 ) depict high levels ofacpmsion of the STM2 mRNA in the basal forebrain (Figure lA) , Layers 516 of the frontal cortex ( Figure 1B ). and in the CA1 ( Figure IC ) and CA3 ( Figure  ID) fields of the hippocampus. High power ( x 4 0 ) brightfield and darkfield photomicrographs comparing the relative lcvcls of STM2 mRNA bctwccn normal and AD affected subjects in these regions are shown in Figures 2 and 3. and quantification of these data is graphically summarized in Figure 4 . Under brightfield microscopy.
the large neurons in the basal forebrain can bc distinguished from the small darkly stained glial cells and the silver grains overlying these putative cholinergic neurons are easily detected (Figures 2A  and 2B ). Localization of the silver grains representing the STM2 mRNA above these large neurons is cvcn more evident in the corresponding darkfield photomicrograph (Figum 2C and 2D) . In contrast, glial cells are not hybridization positive for the STM2 m asage. In Layers 516 of the frontal cortex and in the CA1 and CA3 fields of the hippocampus. the STMZ mRNA is again clearly exp r d in the larger neuronal cells rather than in the smaller. darkly stained glial cells ( Figures 2E-2H and 3A-H. respectively). It is mident from Figures 2 and 3 that the hybridization signal for STM2 mRNA is reduced in the basal forebrain. Layers 516 of the frontal cortex. and the CA1 field ofthe hippocampus in AD subjects relative to controls. STMZ mRNA levels were reduced by 48% in the basal forebrain. by 50% in Layers 516 of the frontal cortex, and by 51% in the CA1 field of the hippocampus (Figure 4) . In contrast, although the levels of STM2 mRNA were reduced by 35% in the CA3 field of the hippocampus of AD subjects (Figure 4) .
this decrease was not statistically significant (p0.09).
The widespread neuronal pattem of STMZ gene expression and its apparent absence in glial cells indicate that its localization in the human CNS is predominantly neuronal. To further support this hypothesis, a human neuroblastoma cell line (SK-N-SH), which assumes a distinct neuronal phenotype after tmtment with NGF (Chen et al.. 1990). was examined for expression ofSTM2 mRNA.
Cells were untmted or treated with 200 nglml of NGF for 3 or 9 days. As previously reported by Chen et al. ( l w ) , cells treated with NGF for 3 or 9 days exhibited many long-branched neurite compared to untmted cells (data not shown). After tmtment with NGF. poly A( +) mRNA was isolated and subjected to Northern analysis. As shown in Figure 5 . a single transcript approximately 2 . 3 -~~ in size was detected in the SK-N-SH cell line. This transcript is similar in size to the smaller STMZ transcript reported to be expressed in the human brain (Levy-Lahad et al., 1335; Rogaev et al.. 1995) . Treatment of this cell line with NGF did not alter the steady-state lcvcl of the STMZ message that was observed in untreated cells.
Discussion
In situ hybridization histochemistry results indicate that the STM2 gene is predominately expressed in neurons of the human brain and is abundant in cells known to be affected by AD. A recent report (Kovacs et al.. 1336 ) has also demonstrated neuronal expmsion of STM2 in the temporal lobe of a neuropathologically normal human subject. In addition, we have provided further support for neuronal acpmsion ofthe STM2 gene by detection ofSTM2 brightfield microscopy (A,B,  EF) , the large neuronal cells (arrows) in the basal forebrain and frontal cortex are clearly distinguishable hom the small, darkly stained glial cells. The corresponding dark- field photomicrographs (C,D.G,H) show the distribution of silver grains overlying thew neuronal cells (arrows). The specificity of the STM2 riboorobe used in this assay was AD _. with a which ita not mRNA in a cell line with neuronal origins. The SK-N-SH cell line is derived from the neural crest and shares some neurochemical properties with neurons. This cell line expresses noradrenergic biosynthetic enzymes, opioid, muscarinic, and NGF receptors, and possesses a mechanism for uptake of norepinephrine (Ciccarone et al., 1989) . These cells exhibit distinct morphological features of neurons after treatment with NGE However, even before NGF treatment this cell line possesses a neuronal phenotype consisting of round or only slightly flattened cell bodies and short neurites, which become more extended in response to NGF. Although we found no difference in the steady-state level ofSTM2 &A in untreated vs NGFtreated cells, the presence of this message in this neuronal cell line lends support to the hypothesis that the expression of the STM2 gene in the brain is primarily neuronal. Howcvrr. these mla do not exclude the expression of STM2 in glial cells, and appropriate cell lines will have to be examined for expression of the STM2 gene to address the question of glial expression more directly.
The role of the STM2 protein in the development of AD is presently unknown. Homology with the spe4 protein suggests that it may be involved in the cytoplasmic partitioning of proteins, and micrographs (C.D.G.H) show the distribution of silver grains overlying these neuronal cells (arrows). The specificity of the STMP riboprobe used in this assay was verified previously by hybridization with a 35S-labeled sense control riboprobe. which failed to N AD it has been postulated that it may be involved in the intracellular trafficking of APP (Levy-Lahad et al., 1995) . The even greater degree of sequence conservation with the sel-12 protein suggests that the STM2 protein may play a role in specifying cell fate during development. However. it is unclear at this point what role this protein would play in adulthood. A recent article (Dewji and Singer, 1996) suggests that the APP, STM2, and S182 proteins are all directly involved in the processes leading to AB formation and ultimately to AD. The authors propose that STM2 (or, alternatively, S182) and APP interact with one another in a manner analogous to the inter-action of the sevenless (SEV) protein and the bride of sevenless (BOSS) seven-transmembrane-spanning protein that are involved in photoreceptor differentiation. The authors suggest that APP on the surface of a neuron interacts with the STM2 protein on the surface of a neighboring auxiliary cell, resulting in vesicular internalization of these two proteins into the neuron, followed by proteolytic cleavage of APP to AB. AB would then be released from the cell, where it would ultimately be found in neuritic plaques. In support of this hypothesis, studies indicate that the multiple membrane-spanning protein sel-12, which is highly homologous BASAL FOREBRAIN FRONTAL CORTEX Normal AD to STMZ, and the integral membrane protein lin-12 interact with one another in a similar manner. It has been suggested that the STM2 protein is not expressed in neuronal cells but rather is expressed in auxiliary cells such as glia. However, our findings and those of Kovacs et al. (1996) indicate that the expression of STM2 is primarily neuronal rather than glial. Therefore, vesicular internalization of these cell surface proteins by this mechanism would have to occur between neurons rather than between neurons and auxiliary cells.
Our data indicate that STM2 gene expression in the basal forebrain, frontal cortex, and hippocampus is reduced in AD-affected subjects compared to normal age-matched controls. It is unlikely that this decrease in expression reflects a decrease in the number of positively labeled cells, as the decrease in STM2 mRNA steadystate levels was detected on a per-cell basis. However, it is well documented that neurons in the basal forebrain, frontal cortex, and hippocampus are severely affected in AD. Therefore, the decrease in steady-state levels of STM2 mRNA in these regions may reflect the unhealthy state of these severely compromised neurons during late stages of the disease. Interestingly, although the levels of STM2 mRNA were reduced in the CA3 field of the hippocampus, we did not find this decrease to be statistically significant. This finding is not surprising, because it is known that neurons in the CA3 field of the hippocampus are not as severely affected in AD as are neurons in the CA1 field (Braak and Braak, 1991; Brady and Mufson, 1991) . There are several other studies describing decreased gene expression in AD (Callahan et al., 1994; Chandrasekaran et al., 1994; Strada et al., 1992) , and it remains to be determined if this decrease plays a causative role in the development of AD or is merely a symptom of the disease. If down-regulation of gene expression is a common manifestation of AD, then most genes should be affected in this manner. However, the expression of many genes remains unaltered in AD subjects compared to controls, even in regions with severe neuropathology. For example, there are no differences in the levels of glutamate, glucocorticoid, and mineralocorticoid receptor " A s in the hippocampus, or cannabinoid receptor mRNAs in the basal forebrain of AD subjects compared to controls (Westlake et al., 1994; Pellegrini-Giampietro et al., 19%; Seck1 et al., 1993; Potier et al., 1992) . In addition, Jett'e et al. (1994) report that the levels of the general mRNA population, and of NGF mRNA in particular, are unchanged in the frontal cortex of individuals affected with AD. In the temporal lobe, a region in which AD-associated brain pathology is prevalent, even common housekeeping genes such as actin and histone remain unchanged in AD subjects compared to normal controls (Kittur et al., 1993) . These data suggest that the decrease in STMZ expression observed in this study is not simply a result of the severe neuropathology characteristic of AD. A more interesting interpretation of the decrease in STM2 gene expression is that this decrease is involved in the progression of AD. In support of this hypothesis, Vito et al. (1996) have recently reported the identification of AGL3. a gene homologous to STM2, that rescues a T-cell hybridoma from T-cell receptor-and Fas-induced apoptosis. If STM2 plays a similar role in rescuing cells from apoptosis. a decrease in its expression could result in premature death of nerve cells and ultimately in AD.
The subjects in this study were diagnosed with late-onset sporadic AD and it is unlikely that they carry the point mutations in the STM2 gene that have been linked to the disease. Therefore. mutations in the STM2 gene must not be responsible for the decrease in STM2 steady-state mRNA levels in sporadic late-onset AD. Thex data suggest that the function of this protein in the development of AD may not be limited to early-onset FAD and may perhaps be more widespread. It will be important to determine the level of expression of the STM2 gene in Volga German kindreds when tissue becomes available. If thex families also exhibit a decrease in STM2 expression, then it is possible that mutations in this gene could lead to decreased gene expression at an earlier age. resulting in earlier development of the disease. In contrast, the development of sporadic late-onset AD may involve as yet undetermined cellular events leading to a decrease in STMZ gene expression and the development of the disease later in life.
A more general role for the STM2 protein in the pathogenesis of AD is not without precedent. Recent studies have demonstrated the presence of a carboxyl fragment of the s182 protein in AD neuritic plaques (Wisnicwski et al.. 1995) . The authors suggest that the presence of the S182 protein in a major neuropathological le-sion that characterizes the disease indicates that the role of this protein in the development of AD may not be limited to chromosome 14-linked families. It has yet to be determined whether the STM2 protein is prexnt in neuritic plaques. However. given the high degree of homology of thex proteins. it appears likely that STM2 will also be present.
In conclusion, these data show that the expression ofthe sTM2 gene is diminished in xved regions of the brain that arc known to be severely a f k t e d in AD. The decreve in expression of this gene in late-onset sporadic AD and the recent finding ofthe SI82 protein in senile plaques suggest a more general role for thex FADlinked genes in the progression of AD. Whether the decreve in STM2 gene expression observed in this study is involved in the progression of AD or is merely a secondary effect of the discax has yet to be determined. To more fully undemand the events Ieading to the development of AD, it will be important to determine the intemlationships among all of the gene products associated with both early-onset FAD and late-onset sporadic AD.
